Determining which patients with myelodysplastic syndrome will respond to immunosuppressive treatment

MeSH terms

• Adult
• Age Factors
• Aged
• Antilymphocyte Serum / therapeutic use*
• Autoimmune Diseases / complications
• Autoimmune Diseases / drug therapy
• Autoimmune Diseases / genetics
• Blood Transfusion
• Chromosomes, Human, Pair 8
• Cyclosporine / therapeutic use*
• Etanercept
• HLA-DR Antigens / analysis
• Humans
• Immunoglobulin G / therapeutic use
• Immunosuppressive Agents / therapeutic use*
• Middle Aged
• Multicenter Studies as Topic
• Myelodysplastic Syndromes / complications
• Myelodysplastic Syndromes / drug therapy*
• Myelodysplastic Syndromes / genetics
• Myelodysplastic Syndromes / immunology
• Pancytopenia / drug therapy
• Pancytopenia / etiology
• Patient Selection*
• Predictive Value of Tests
• Prognosis
• Receptors, Tumor Necrosis Factor / therapeutic use
• T-Lymphocytes
• Treatment Outcome
• Trisomy
• Tumor Necrosis Factor-alpha / antagonists & inhibitors